查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1859920

Metformin Hydrochloride：全球市場佔有率和排名、總銷售額和需求預測（2025-2031 年）

Metformin Hydrochloride - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球Metformin Hydrochloride市場預計在 2024 年達到 3.91 億美元，預計到 2031 年將達到 5.84 億美元，2025 年至 2031 年的複合年成長率為 6.3%。

本報告對近期有關Metformin Hydrochloride跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的關稅調整和國際戰略反制措施進行了全面評估。

Metformin Hydrochloride是生產成品Metformin Hydrochloride製劑的原料。本品為Metformin Hydrochloride原料藥（API）。成品Metformin Hydrochloride是一種口服降血糖藥，用於治療第二型糖尿病。Metformin Hydrochloride（N,N-二甲基亞氨基二碳醯亞胺醯胺鹽酸鹽）在化學和藥理學上與其他口服降血糖藥物無關。Metformin Hydrochloride為白色至淡黃色結晶質化合物，分子式為C4H11N5HCl，分子量為165.63。Metformin Hydrochloride易溶於水，幾乎不溶於丙酮、乙醚和氯仿。本報告提供有關鹽酸二甲雙胍活性藥物成分（API）的統計數據。 2024年，全球Metformin Hydrochloride市場規模達到約66,400噸，全球平均市場價格約每噸5,894美元。

Metformin Hydrochloride是一種廣泛使用的口服降血糖藥物，主要用於治療第二型糖尿病。它屬於雙胍類藥物，透過抑制肝醣異生、減少腸道葡萄糖吸收和提高周邊組織胰島素敏感性發揮作用。其確切的療效、安全性以及低廉的價格使其成為全球數百萬患者的一線治療藥物。全球市場高度標準化，產能約12萬噸，毛利率相對較低，為6%至20%，單一生產線的產能通常在3000至5000噸之間。這反映出一個成熟的、大規模的醫藥中間體市場。

上游工程產業鏈始於二甲胺鹽酸鹽和雙氰胺等原料，這些原料經化學合成生成二甲雙胍鹼。此中間體隨後經鹽酸結晶提純，Metformin Hydrochloride。在中游環節，生產商將原料藥（API）加工成原料藥，或供應給製劑生產商。下游環節，學名藥生產商生產片劑、緩釋性以及與其他抗糖尿病藥物的固定劑量複方組合藥物，佔據了大部分需求。該行業結構的特點是原料藥生產商之間競爭激烈，尤其是在中國和印度，這兩個國家供應了全球大部分的原料藥需求。

市場成長的關鍵促進因素是全球第2型糖尿病盛行率的不斷上升，這主要歸因於人口老化、缺乏運動以及飲食習慣的改變，尤其是在開發中國家。新興國家醫療保健服務的改善持續擴大了二甲雙胍類治療方法的患者群體。此外，國際指引廣泛認可二甲雙胍作為糖尿病治療的基石，也確保了其穩定的需求。其他促進因素包括探索其在非糖尿病領域的應用，例如治療卵巢症候群（PCOS），以及在老齡化相關疾病和腫瘤治療中的潛在用途，進一步拓寬了其臨床應用範圍。儘管面臨激烈的價格競爭和較低的利潤率，二甲雙胍在糖尿病治療中的關鍵作用仍能確保其市場的長期穩定。

本報告旨在按地區/國家、類型和應用對全球Metformin Hydrochloride市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（噸）和收入（百萬美元）為單位，對Metformin Hydrochloride市場規模、估算和預測進行了呈現，以2024年為基準年，並包含了2020年至2031年期間的歷史數據和預測數據。本報告運用定量和定性分析，幫助讀者制定業務/成長策略、評估市場競爭、分析自身在當前市場中的地位，並就Metformin Hydrochloride做出明智的商業決策。

市場區隔

公司

  • Wanbury
  • USV
  • Shouguang Fukang Pharmaceutical
  • Vistin Pharma
  • Ningxia Hengkang Technology
  • Keyuan Pharmaceutical
  • FARMHISPANIA GROUP
  • Harman Finochem
  • Shijiazhuang Polee Pharmaceutical
  • Aarti Drugs
  • Exemed Pharmaceuticals
  • Granules

按類型分類的細分市場

  • 鹽酸二甲雙胍
  • 二甲雙胍

應用領域

  • Metformin Hydrochloride片
  • Metformin Hydrochloride緩釋片
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Metformin Hydrochloride was estimated to be worth US$ 391 million in 2024 and is forecast to a readjusted size of US$ 584 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Metformin Hydrochloride cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5*HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.In 2024, global Metformin Hydrochloride reached approximately 66400 MT, with an average global market price of around US$ 5894 per MT.

Metformin Hydrochloride is a widely used oral antihyperglycemic drug, primarily prescribed for the treatment of type 2 diabetes. It belongs to the biguanide class and works by reducing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity in peripheral tissues. Its well-established efficacy, safety profile, and low cost have made it the first-line therapy for millions of patients worldwide. The global market is highly standardized, with a production capacity of about 120,000 tons, a relatively thin gross profit margin of 6%-20%, and single-line production capacities commonly in the range of 3,000-5,000 tons, reflecting a mature, large-scale pharmaceutical intermediate market.

The industry chain begins upstream with raw materials such as dimethylamine hydrochloride and dicyandiamide, which undergo chemical synthesis to produce metformin base. This intermediate is further crystallized and refined with hydrochloric acid to yield metformin hydrochloride in pharmaceutical-grade quality. Midstream, manufacturers formulate the active pharmaceutical ingredient (API) into bulk drug products or supply it to formulation companies. Downstream, the demand is dominated by generic drug manufacturers producing tablets, extended-release formulations, and fixed-dose combinations with other antidiabetic drugs. The industry structure is characterized by significant competition among bulk producers, especially in China and India, which supply the majority of global API demand.

Key market drivers include the growing global prevalence of type 2 diabetes, driven by aging populations, sedentary lifestyles, and dietary changes, particularly in developing countries. Increasing healthcare access in emerging economies continues to expand the patient base for metformin-based therapies. Moreover, the widespread acceptance of metformin as the cornerstone of diabetes management by international guidelines ensures consistent demand. Additional drivers include its applications beyond diabetes, such as polycystic ovary syndrome (PCOS) treatment and research into potential uses in aging-related conditions and oncology, which further broaden its clinical relevance. Despite competitive pricing pressure and low margins, its indispensable role in diabetes care secures long-term market stability.

This report aims to provide a comprehensive presentation of the global market for Metformin Hydrochloride, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metformin Hydrochloride by region & country, by Type, and by Application.

The Metformin Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Hydrochloride.

Market Segmentation

By Company

  • Wanbury
  • USV
  • Shouguang Fukang Pharmaceutical
  • Vistin Pharma
  • Ningxia Hengkang Technology
  • Keyuan Pharmaceutical
  • FARMHISPANIA GROUP
  • Harman Finochem
  • Shijiazhuang Polee Pharmaceutical
  • Aarti Drugs
  • Exemed Pharmaceuticals
  • Granules

Segment by Type

  • Metformin HCL
  • Metformin DC

Segment by Application

  • Metformin Hydrochloride Tablets
  • Metformin Hydrochloride Extended-Release Tablets
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Metformin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Metformin Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Metformin Hydrochloride in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Metformin Hydrochloride Product Introduction
  • 1.2 Global Metformin Hydrochloride Market Size Forecast
    • 1.2.1 Global Metformin Hydrochloride Sales Value (2020-2031)
    • 1.2.2 Global Metformin Hydrochloride Sales Volume (2020-2031)
    • 1.2.3 Global Metformin Hydrochloride Sales Price (2020-2031)
  • 1.3 Metformin Hydrochloride Market Trends & Drivers
    • 1.3.1 Metformin Hydrochloride Industry Trends
    • 1.3.2 Metformin Hydrochloride Market Drivers & Opportunity
    • 1.3.3 Metformin Hydrochloride Market Challenges
    • 1.3.4 Metformin Hydrochloride Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Metformin Hydrochloride Players Revenue Ranking (2024)
  • 2.2 Global Metformin Hydrochloride Revenue by Company (2020-2025)
  • 2.3 Global Metformin Hydrochloride Players Sales Volume Ranking (2024)
  • 2.4 Global Metformin Hydrochloride Sales Volume by Company Players (2020-2025)
  • 2.5 Global Metformin Hydrochloride Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Metformin Hydrochloride Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Metformin Hydrochloride Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Metformin Hydrochloride
  • 2.9 Metformin Hydrochloride Market Competitive Analysis
    • 2.9.1 Metformin Hydrochloride Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Metformin Hydrochloride Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Hydrochloride as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Metformin HCL
    • 3.1.2 Metformin DC
  • 3.2 Global Metformin Hydrochloride Sales Value by Type
    • 3.2.1 Global Metformin Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Metformin Hydrochloride Sales Value, by Type (2020-2031)
    • 3.2.3 Global Metformin Hydrochloride Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Metformin Hydrochloride Sales Volume by Type
    • 3.3.1 Global Metformin Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Metformin Hydrochloride Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Metformin Hydrochloride Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Metformin Hydrochloride Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Metformin Hydrochloride Tablets
    • 4.1.2 Metformin Hydrochloride Extended-Release Tablets
    • 4.1.3 Others
  • 4.2 Global Metformin Hydrochloride Sales Value by Application
    • 4.2.1 Global Metformin Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Metformin Hydrochloride Sales Value, by Application (2020-2031)
    • 4.2.3 Global Metformin Hydrochloride Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Metformin Hydrochloride Sales Volume by Application
    • 4.3.1 Global Metformin Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Metformin Hydrochloride Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Metformin Hydrochloride Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Metformin Hydrochloride Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Metformin Hydrochloride Sales Value by Region
    • 5.1.1 Global Metformin Hydrochloride Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Metformin Hydrochloride Sales Value by Region (2020-2025)
    • 5.1.3 Global Metformin Hydrochloride Sales Value by Region (2026-2031)
    • 5.1.4 Global Metformin Hydrochloride Sales Value by Region (%), (2020-2031)
  • 5.2 Global Metformin Hydrochloride Sales Volume by Region
    • 5.2.1 Global Metformin Hydrochloride Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Metformin Hydrochloride Sales Volume by Region (2020-2025)
    • 5.2.3 Global Metformin Hydrochloride Sales Volume by Region (2026-2031)
    • 5.2.4 Global Metformin Hydrochloride Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Metformin Hydrochloride Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Metformin Hydrochloride Sales Value, 2020-2031
    • 5.4.2 North America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Metformin Hydrochloride Sales Value, 2020-2031
    • 5.5.2 Europe Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Metformin Hydrochloride Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Metformin Hydrochloride Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Metformin Hydrochloride Sales Value, 2020-2031
    • 5.7.2 South America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Metformin Hydrochloride Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Metformin Hydrochloride Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Metformin Hydrochloride Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Metformin Hydrochloride Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Metformin Hydrochloride Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Metformin Hydrochloride Sales Value, 2020-2031
    • 6.3.2 United States Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Metformin Hydrochloride Sales Value, 2020-2031
    • 6.4.2 Europe Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Metformin Hydrochloride Sales Value, 2020-2031
    • 6.5.2 China Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Metformin Hydrochloride Sales Value, 2020-2031
    • 6.6.2 Japan Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Metformin Hydrochloride Sales Value, 2020-2031
    • 6.7.2 South Korea Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Metformin Hydrochloride Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Metformin Hydrochloride Sales Value, 2020-2031
    • 6.9.2 India Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Metformin Hydrochloride Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Wanbury
    • 7.1.1 Wanbury Company Information
    • 7.1.2 Wanbury Introduction and Business Overview
    • 7.1.3 Wanbury Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Wanbury Metformin Hydrochloride Product Offerings
    • 7.1.5 Wanbury Recent Development
  • 7.2 USV
    • 7.2.1 USV Company Information
    • 7.2.2 USV Introduction and Business Overview
    • 7.2.3 USV Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 USV Metformin Hydrochloride Product Offerings
    • 7.2.5 USV Recent Development
  • 7.3 Shouguang Fukang Pharmaceutical
    • 7.3.1 Shouguang Fukang Pharmaceutical Company Information
    • 7.3.2 Shouguang Fukang Pharmaceutical Introduction and Business Overview
    • 7.3.3 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Product Offerings
    • 7.3.5 Shouguang Fukang Pharmaceutical Recent Development
  • 7.4 Vistin Pharma
    • 7.4.1 Vistin Pharma Company Information
    • 7.4.2 Vistin Pharma Introduction and Business Overview
    • 7.4.3 Vistin Pharma Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Vistin Pharma Metformin Hydrochloride Product Offerings
    • 7.4.5 Vistin Pharma Recent Development
  • 7.5 Ningxia Hengkang Technology
    • 7.5.1 Ningxia Hengkang Technology Company Information
    • 7.5.2 Ningxia Hengkang Technology Introduction and Business Overview
    • 7.5.3 Ningxia Hengkang Technology Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Ningxia Hengkang Technology Metformin Hydrochloride Product Offerings
    • 7.5.5 Ningxia Hengkang Technology Recent Development
  • 7.6 Keyuan Pharmaceutical
    • 7.6.1 Keyuan Pharmaceutical Company Information
    • 7.6.2 Keyuan Pharmaceutical Introduction and Business Overview
    • 7.6.3 Keyuan Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Keyuan Pharmaceutical Metformin Hydrochloride Product Offerings
    • 7.6.5 Keyuan Pharmaceutical Recent Development
  • 7.7 FARMHISPANIA GROUP
    • 7.7.1 FARMHISPANIA GROUP Company Information
    • 7.7.2 FARMHISPANIA GROUP Introduction and Business Overview
    • 7.7.3 FARMHISPANIA GROUP Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 FARMHISPANIA GROUP Metformin Hydrochloride Product Offerings
    • 7.7.5 FARMHISPANIA GROUP Recent Development
  • 7.8 Harman Finochem
    • 7.8.1 Harman Finochem Company Information
    • 7.8.2 Harman Finochem Introduction and Business Overview
    • 7.8.3 Harman Finochem Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Harman Finochem Metformin Hydrochloride Product Offerings
    • 7.8.5 Harman Finochem Recent Development
  • 7.9 Shijiazhuang Polee Pharmaceutical
    • 7.9.1 Shijiazhuang Polee Pharmaceutical Company Information
    • 7.9.2 Shijiazhuang Polee Pharmaceutical Introduction and Business Overview
    • 7.9.3 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Product Offerings
    • 7.9.5 Shijiazhuang Polee Pharmaceutical Recent Development
  • 7.10 Aarti Drugs
    • 7.10.1 Aarti Drugs Company Information
    • 7.10.2 Aarti Drugs Introduction and Business Overview
    • 7.10.3 Aarti Drugs Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Aarti Drugs Metformin Hydrochloride Product Offerings
    • 7.10.5 Aarti Drugs Recent Development
  • 7.11 Exemed Pharmaceuticals
    • 7.11.1 Exemed Pharmaceuticals Company Information
    • 7.11.2 Exemed Pharmaceuticals Introduction and Business Overview
    • 7.11.3 Exemed Pharmaceuticals Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Exemed Pharmaceuticals Metformin Hydrochloride Product Offerings
    • 7.11.5 Exemed Pharmaceuticals Recent Development
  • 7.12 Granules
    • 7.12.1 Granules Company Information
    • 7.12.2 Granules Introduction and Business Overview
    • 7.12.3 Granules Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Granules Metformin Hydrochloride Product Offerings
    • 7.12.5 Granules Recent Development

8 Industry Chain Analysis

  • 8.1 Metformin Hydrochloride Industrial Chain
  • 8.2 Metformin Hydrochloride Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Metformin Hydrochloride Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Metformin Hydrochloride Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Metformin Hydrochloride Market Trends
  • Table 2. Metformin Hydrochloride Market Drivers & Opportunity
  • Table 3. Metformin Hydrochloride Market Challenges
  • Table 4. Metformin Hydrochloride Market Restraints
  • Table 5. Global Metformin Hydrochloride Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Metformin Hydrochloride Revenue Market Share by Company (2020-2025)
  • Table 7. Global Metformin Hydrochloride Sales Volume by Company (2020-2025) & (MT)
  • Table 8. Global Metformin Hydrochloride Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Metformin Hydrochloride Price by Company (2020-2025) & (US$/MT)
  • Table 10. Key Manufacturers Metformin Hydrochloride Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Metformin Hydrochloride Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Metformin Hydrochloride
  • Table 13. Global Metformin Hydrochloride Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Hydrochloride as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Metformin Hydrochloride Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Metformin Hydrochloride Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Metformin Hydrochloride Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Metformin Hydrochloride Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Metformin Hydrochloride Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Metformin Hydrochloride Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
  • Table 22. Global Metformin Hydrochloride Sales Volume by Type (2020-2025) & (MT)
  • Table 23. Global Metformin Hydrochloride Sales Volume by Type (2026-2031) & (MT)
  • Table 24. Global Metformin Hydrochloride Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Metformin Hydrochloride Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Metformin Hydrochloride Price by Type (2020-2025) & (US$/MT)
  • Table 27. Global Metformin Hydrochloride Price by Type (2026-2031) & (US$/MT)
  • Table 28. Global Metformin Hydrochloride Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Metformin Hydrochloride Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Metformin Hydrochloride Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Metformin Hydrochloride Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Metformin Hydrochloride Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Metformin Hydrochloride Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
  • Table 34. Global Metformin Hydrochloride Sales Volume by Application (2020-2025) & (MT)
  • Table 35. Global Metformin Hydrochloride Sales Volume by Application (2026-2031) & (MT)
  • Table 36. Global Metformin Hydrochloride Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Metformin Hydrochloride Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Metformin Hydrochloride Price by Application (2020-2025) & (US$/MT)
  • Table 39. Global Metformin Hydrochloride Price by Application (2026-2031) & (US$/MT)
  • Table 40. Global Metformin Hydrochloride Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Metformin Hydrochloride Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Metformin Hydrochloride Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Metformin Hydrochloride Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Metformin Hydrochloride Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Metformin Hydrochloride Sales Volume by Region (MT): 2020 VS 2024 VS 2031
  • Table 46. Global Metformin Hydrochloride Sales Volume by Region (2020-2025) & (MT)
  • Table 47. Global Metformin Hydrochloride Sales Volume by Region (2026-2031) & (MT)
  • Table 48. Global Metformin Hydrochloride Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Metformin Hydrochloride Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Metformin Hydrochloride Average Price by Region (2020-2025) & (US$/MT)
  • Table 51. Global Metformin Hydrochloride Average Price by Region (2026-2031) & (US$/MT)
  • Table 52. Key Countries/Regions Metformin Hydrochloride Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Metformin Hydrochloride Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Metformin Hydrochloride Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Metformin Hydrochloride Sales Volume, (2020-2025) & (MT)
  • Table 56. Key Countries/Regions Metformin Hydrochloride Sales Volume, (2026-2031) & (MT)
  • Table 57. Wanbury Company Information
  • Table 58. Wanbury Introduction and Business Overview
  • Table 59. Wanbury Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 60. Wanbury Metformin Hydrochloride Product Offerings
  • Table 61. Wanbury Recent Development
  • Table 62. USV Company Information
  • Table 63. USV Introduction and Business Overview
  • Table 64. USV Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 65. USV Metformin Hydrochloride Product Offerings
  • Table 66. USV Recent Development
  • Table 67. Shouguang Fukang Pharmaceutical Company Information
  • Table 68. Shouguang Fukang Pharmaceutical Introduction and Business Overview
  • Table 69. Shouguang Fukang Pharmaceutical Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 70. Shouguang Fukang Pharmaceutical Metformin Hydrochloride Product Offerings
  • Table 71. Shouguang Fukang Pharmaceutical Recent Development
  • Table 72. Vistin Pharma Company Information
  • Table 73. Vistin Pharma Introduction and Business Overview
  • Table 74. Vistin Pharma Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 75. Vistin Pharma Metformin Hydrochloride Product Offerings
  • Table 76. Vistin Pharma Recent Development
  • Table 77. Ningxia Hengkang Technology Company Information
  • Table 78. Ningxia Hengkang Technology Introduction and Business Overview
  • Table 79. Ningxia Hengkang Technology Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 80. Ningxia Hengkang Technology Metformin Hydrochloride Product Offerings
  • Table 81. Ningxia Hengkang Technology Recent Development
  • Table 82. Keyuan Pharmaceutical Company Information
  • Table 83. Keyuan Pharmaceutical Introduction and Business Overview
  • Table 84. Keyuan Pharmaceutical Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 85. Keyuan Pharmaceutical Metformin Hydrochloride Product Offerings
  • Table 86. Keyuan Pharmaceutical Recent Development
  • Table 87. FARMHISPANIA GROUP Company Information
  • Table 88. FARMHISPANIA GROUP Introduction and Business Overview
  • Table 89. FARMHISPANIA GROUP Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 90. FARMHISPANIA GROUP Metformin Hydrochloride Product Offerings
  • Table 91. FARMHISPANIA GROUP Recent Development
  • Table 92. Harman Finochem Company Information
  • Table 93. Harman Finochem Introduction and Business Overview
  • Table 94. Harman Finochem Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 95. Harman Finochem Metformin Hydrochloride Product Offerings
  • Table 96. Harman Finochem Recent Development
  • Table 97. Shijiazhuang Polee Pharmaceutical Company Information
  • Table 98. Shijiazhuang Polee Pharmaceutical Introduction and Business Overview
  • Table 99. Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 100. Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Product Offerings
  • Table 101. Shijiazhuang Polee Pharmaceutical Recent Development
  • Table 102. Aarti Drugs Company Information
  • Table 103. Aarti Drugs Introduction and Business Overview
  • Table 104. Aarti Drugs Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 105. Aarti Drugs Metformin Hydrochloride Product Offerings
  • Table 106. Aarti Drugs Recent Development
  • Table 107. Exemed Pharmaceuticals Company Information
  • Table 108. Exemed Pharmaceuticals Introduction and Business Overview
  • Table 109. Exemed Pharmaceuticals Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 110. Exemed Pharmaceuticals Metformin Hydrochloride Product Offerings
  • Table 111. Exemed Pharmaceuticals Recent Development
  • Table 112. Granules Company Information
  • Table 113. Granules Introduction and Business Overview
  • Table 114. Granules Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 115. Granules Metformin Hydrochloride Product Offerings
  • Table 116. Granules Recent Development
  • Table 117. Key Raw Materials Lists
  • Table 118. Raw Materials Key Suppliers Lists
  • Table 119. Metformin Hydrochloride Downstream Customers
  • Table 120. Metformin Hydrochloride Distributors List
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Metformin Hydrochloride Product Picture
  • Figure 2. Global Metformin Hydrochloride Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Metformin Hydrochloride Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Metformin Hydrochloride Sales Volume (2020-2031) & (MT)
  • Figure 5. Global Metformin Hydrochloride Sales Price (2020-2031) & (US$/MT)
  • Figure 6. Metformin Hydrochloride Report Years Considered
  • Figure 7. Global Metformin Hydrochloride Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Metformin Hydrochloride Players Sales Volume Ranking (2024) & (MT)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Metformin Hydrochloride Revenue in 2024
  • Figure 10. Metformin Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Metformin HCL Picture
  • Figure 12. Metformin DC Picture
  • Figure 13. Global Metformin Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Metformin Hydrochloride Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Metformin Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
  • Figure 16. Global Metformin Hydrochloride Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Metformin Hydrochloride Price by Type (2020-2031) & (US$/MT)
  • Figure 18. Product Picture of Metformin Hydrochloride Tablets
  • Figure 19. Product Picture of Metformin Hydrochloride Extended-Release Tablets
  • Figure 20. Product Picture of Others
  • Figure 21. Global Metformin Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Metformin Hydrochloride Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Metformin Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
  • Figure 24. Global Metformin Hydrochloride Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Metformin Hydrochloride Price by Application (2020-2031) & (US$/MT)
  • Figure 26. North America Metformin Hydrochloride Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Metformin Hydrochloride Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Metformin Hydrochloride Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Metformin Hydrochloride Sales Volume (%), (2020-2031)
  • Figure 38. United States Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Metformin Hydrochloride Industrial Chain
  • Figure 60. Metformin Hydrochloride Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed